Hemant Surgical Industries Complete Financial Statements
HSIL • Review detailed financials to uncover trends, confirm thesis & journal trades
1 Years of Data
2025 - 2025
Complete Financial Data Export
Export complete financial statements for Hemant Surgical Industries (HSIL).
Downloads include all available records across all periods.
Profitability Ratios
Net Profit Margin
7.14%
2025 data
EBITDA Margin
12.50%
2025 data
Operating Margin
8.00%
2025 data
Return on Assets
5.41%
2025 data
Return on Equity
12.70%
2025 data
Balance Sheet Ratios
Current Ratio
3.71
2025 data
Equity Ratio
42.57%
2025 data
Asset Turnover
0.76
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 |
|---|---|---|
| Revenue | 0 | 112 |
| Expenses | 0 | 98 |
| EBITDA | 0 | 14 |
| Operating Profit Margin % | 0.00% | 8.00% |
| Depreciation | 0 | 1 |
| Interest | 0 | 2 |
| Profit Before Tax | 0 | 11 |
| Tax | 0 | 2 |
| Net Profit | 0 | 8 |
| Earnings Per Share (₹) | 0.00 | 7.70 |
Related Pages for Hemant Surgical Industries
Additional stock information and data for HSIL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 |
|---|---|
| ASSETS | |
| Total Assets | 148 |
| Current Assets | 89 |
| Fixed Assets | 40 |
| Capital Work in Progress | 12 |
| Investments | 0 |
| Other Assets | 97 |
| LIABILITIES | |
| Total Liabilities | |
| Current Liabilities | 24 |
| Non-Current Liabilities | |
| SHAREHOLDERS' EQUITY | |
| Total Equity | 63 |
| Share Capital | 10 |
| Reserves & Surplus | 53 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 |
|---|---|
| Operating Activities | 9 |
| Investing Activities | -30 |
| Financing Activities | 18 |
| Net Cash Flow | -4 |